Comparison of centchroman and PPIUCD in terms of efficacy, safety and continuation rate in immediate postpartum period

Gupta, M. D.; Bansiwal, Reeta; Anand, HP

doi:10.18203/2320-1770.ijrcog20205769

Cited by 2 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Centchroman was introduced into the family planning basket of contraceptives but is underutilised as a postpartum spacing method despite its safety and convenient dosing schedule. Recent studies have demonstrated that centchroman has higher satisfaction and continuation rates than postpartum intrauterine devices and progesterone-only pills [1,4]. No untoward side effects have been reported with centchroman use till now [2].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Improving the Acceptance Rate of Centchroman As a Postpartum Contraceptive Through a Quality Improvement Initiative

Sarkar¹,

Wadhawan²,

Raj³

et al. 2022

Cureus

View full text Add to dashboard Cite

BackgroundThe unmet need for contraception is two-pronged: a spacing method and a permanent method. Centchroman, a non-hormonal, non-steroidal oral contraceptive, is suitable for both of these purposes. The Government of India provides it free of cost under the name "Chhaya", but its current acceptance rates are lower than expected. We aimed to increase the acceptance rates of centchroman as a postpartum contraceptive through a quality improvement (QI) approach conducted over eight months at a tertiary care hospital in North India. Materials and MethodsThis QI study was done in three phases: a pre-intervention phase of over eight weeks to assess the baseline acceptance and prevalence rates of centchroman use; an intervention phase of over 12 weeks involving three Plan-Do-Study-Act (PDSA) cycles to increase the awareness and acceptance of centchroman among the target population using visual aids and counselling by the nursing staff and resident doctors, respectively; and a post-intervention phase of over 12 weeks to assess the acceptance and continuation rates of Chhaya. ResultsThe acceptance rates for centchroman increased from a baseline of 2.9% to 15.3%, 56.3%, and 78.2% after the first, second, and third PDSA cycles, respectively. On follow-up, continuation rates were 96.7%, 89.5%, and 78.6% at one, three, and six months, respectively. The majority of women reported only minor side effects, with the primary reason for discontinuation being a preference for intrauterine devices or medroxyprogesterone acetate injections over Chhaya. ConclusionThe postpartum period provides an important window of opportunity to counsel women for contraception. Despite an enviable safety profile and dosing schedule, centchroman remains largely under-utilized. Increasing awareness among women as well as health care workers may improve the acceptance of centchroman and help reduce the burden of untimely and unwanted conceptions.

show abstract

Section: Discussionmentioning

confidence: 99%

“…There are very few studies available regarding the acceptance rates of centchroman in India. The acceptance rates widely range from 60 to 77.5% [1,4]. However, no literature exists on the contraceptive acceptance rate of centchroman in the postpartum period.…”

Section: Introductionmentioning

confidence: 99%

Improving the Acceptance Rate of Centchroman As a Postpartum Contraceptive Through a Quality Improvement Initiative

Sarkar¹,

Wadhawan²,

Raj³

et al. 2022

Cureus

View full text Add to dashboard Cite

show abstract

Perception, Misconceptions and Satisfaction Regarding Chhaya (Non-Hormonal Weekly Centchroman Pill) Among Women Within Reproductive Age Group Attending Gynecological Out Patient Department in a Selected Hospital, Kolkata

Roy,

Mazumder,

Ghosh

2024

Int. J. Res. Granthaalayah

View full text Add to dashboard Cite

Population growth is a serious threat to the international community and a major obstacle for nation’s social and economic development, moreover it is one of the biggest problems developing country like India is facing at the moment and to satisfy the need of contraceptive as well as to fulfill the undertaking of the 2030 Agenda GOI has introduced ‘Centchroman’, non-hormonal or non-steroid based weekly pill which is relatively safer and better choice as contraceptive for the reproductive age women even for breastfeeding women as it has no side-effects like other steroidal contraceptives.Aim: This study aims to assess the Perception, Misconceptions and Satisfaction regarding CHHAYA (Non-hormonal weekly Centchroman Pill) among women within the reproductive age group attending the Gynecological Out Patient Department in a selected hospital, Kolkata.Methods: An exploratory survey research was carried out with 115 reproductive age group women using CHHAYA attending the Gynecological Out Patient Department in a selected hospital, Kolkata. The Total enumerative sampling technique was employed to select as subjects and the Data was collected by using self-developed, validated demographic proforma, perception assessment scale, misconception rating scale, satisfaction assessment tool through interviewing technique.Results: The findings revealed that of all these women, 51.30% had positive perception, 60% had misconceptions and 55.65% respondents were satisfied with CHHAYA. Statistically a significant relationship was found between the perception and the satisfaction of the women regarding CHHAYA (‘ρ’=0.61, ‘t’ =8.18, p= 0.0008). Statistically significant association found between level of perception and partner’s approval (ꭓ2 = 5.94, p =0.01), duration of use (ꭓ2 = 7.65, p =0.005). It has also been outlined that there was statistically significant association between level of misconception and the religion (ꭓ2 = 6.94, p =0.008), education level of the women (ꭓ2 = 6.16, p =0.01). It also depicted that there was statistically significant association between level of satisfaction and the type of family (ꭓ2 = 8.33, p =0.003), partners approval (ꭓ2 = 4.64, p =0.03), duration of use (ꭓ2 = 8.93, p =0.002).Conclusion: In spite of the fact that CHHAYA is an effective, inexpensive, easily accessible, lack of stringent schedule, safe in terms of side-effects like other OCPs, non-interference with sexual drive, reversible contraceptive method for women who opt for family planning it is mostly underutilized among contraceptives as there is negative perception, strong misconceptions, lack of satisfaction. As it is till now underuse due to insufficient information about it among the women, so collaborative efforts of proper counselling and follow up can be made by the health care providers reducing the misconceptions, discontinuation rates and to sustain compliance to CHHAYA.

show abstract

Comparison of centchroman and PPIUCD in terms of efficacy, safety and continuation rate in immediate postpartum period

Cited by 2 publications

References 3 publications

Improving the Acceptance Rate of Centchroman As a Postpartum Contraceptive Through a Quality Improvement Initiative

Improving the Acceptance Rate of Centchroman As a Postpartum Contraceptive Through a Quality Improvement Initiative

Perception, Misconceptions and Satisfaction Regarding Chhaya (Non-Hormonal Weekly Centchroman Pill) Among Women Within Reproductive Age Group Attending Gynecological Out Patient Department in a Selected Hospital, Kolkata

Contact Info

Product

Resources

About